Inhibition of MLK3 downregulated the expression of FRA-1, MMP-1 and MMP-9, leading to the transendothelial migration and matrigel invasion of triple-negative breast cancer cells [23]. The gene discussed is MAP3K11; the disease is triple-negative breast carcinoma.